The high prevalence of occurrences serves as a reminder that some locations throughout the world have high frequencies of the disease and a very high rate of transmission. According to the World Health Organisation, around 16 million cases of leprosy have been treated in the last two decades. Governing bodies and governments alike are attempting to eradicate the disease on a global basis. Because of these factors, the leprosy treatment market is likely to expand at a rapid pace during the forecast period (2016-2024).
During the forecast time frame of 2022–2030, the market for Leprosy Treatments is anticipated to grow at a 4.8% CAGR to reach USD 4,823.4 million.
Leading Companies in the Leprosy Treatment Industry:
Glaxo Smithcline Pharmaceuticals Ltd.:
1. GSK is one of the major pharmaceutical firms in terms of total sales. The company has clout in a variety of therapeutic areas, including respiratory, cancer, and antiviral drugs, as well as vaccines. GSK employs joint ventures to develop scale in some industries, such as HIV. Founded 2000. The company's headquarters are in England, United Kingdom. The merger of GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited marks a new chapter in India's nutrition story.
Systopic Laboratories Pvt. Ltd.:
2. Systopic Laboratories Private Limited has been supplying the Indian market with high-caliber, cutting-edge pharmaceutical products since 1984. Our formulas have been used by doctors from all medical specialties for more than thirty years, making us a well-known and reliable reputation in the Indian pharmaceutical industry. Head office in Delhi.